This inventor holds 1 USPTO granted patent. Top assignee: University of Ottawa. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Christine Pratt: Innovator in Estrogenic Compounds
Introduction
Christine Pratt is a notable inventor based in Ottawa, Canada. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of estrogenic compounds. Her work is essential for advancing hormone replacement therapies and contraceptive methods.
Latest Patents
Christine Pratt holds a patent for "Estrogenic compounds, process for their production and pharmaceutical uses thereof." This inventive concept provides new estrogenic compounds that are useful in hormone replacement therapies (HRT/ERT) and as contraceptives. The patent also includes a process for synthesizing these compounds, showcasing her innovative approach to addressing hormonal health issues.
Career Highlights
Christine is affiliated with the University of Ottawa, where she continues her research and development in the field of pharmaceuticals. Her dedication to innovation has led to advancements that benefit many individuals seeking hormone-related treatments.
Collaborations
Christine has collaborated with esteemed colleagues, including Hooman Shadnia and Muhammad Asim. These partnerships enhance her research efforts and contribute to the success of her projects.
Conclusion
Christine Pratt's work in developing estrogenic compounds represents a significant advancement in pharmaceutical science. Her contributions are vital for improving hormone therapies and enhancing women's health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile